Asynchronous progression through the lytic cascade and variations in intracellular viral loads revealed by high-throughput single-cell analysis of Kaposi's sarcoma-associated herpesvirus infection

Journal of Virology

Volumn 80, Issue 20, 2006, Pages 10073-10082

  Adang, Laura A ^a   Parsons, Christopher H ^a   Kedes, Dean H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; IMMEDIATE EARLY PROTEIN; LATENCY ASSOCIATED NUCLEAR ANTIGEN; PROTEIN K8.1; PROTEIN RTA; SYNDECAN 1; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; EPISOME; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; HELA CELL; HERPES VIRUS INFECTION; HETEROCHROMATIN; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE; LATENT VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VIRUS CULTURE; VIRUS GENOME; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION;

ANTIGENS, VIRAL; CELL LINE; DNA, VIRAL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOPROTEINS; HERPESVIRUS 8, HUMAN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMEDIATE-EARLY PROTEINS; MEMBRANE GLYCOPROTEINS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROTEOGLYCANS; SYNDECAN-1; SYNDECANS; TRANS-ACTIVATORS; VIRAL LOAD; VIRAL PROTEINS;

HUMAN HERPESVIRUS 8;

EID: 33749496177     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01156-06     Document Type: Article

References (58)

1. Asahi-Ozaki, Y., Y. Sato, T. Kanno, T. Sata, and H. Katano. 2006. Quantitative analysis of Kaposi sarcoma-associated herpesvirus (KSHV) in KSHV-associated diseases. J. Infect. Dis. 193:773-782.
2. Ballestas, M. E., P. A. Chatis, and K. M. Kaye. 1999. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284:641-644.
3. Barbera. A. J., J. V. Chodaparamhil, B. Kelley-Clarke, V. Joukov, J. C. Walter, K. Luger, and K. M. Kaye. 2006. The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311:856-861.
4. Canham, M., and S. J. Talbot. 2004. A naturally occurring C-terminal truncated isoform of the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus does not associate with viral episomal DNA. J. Gen. Virol. 85:1363-1369.
5. Chandran, D., C. Bloomer, S. R. Chan, L. J. Zhu, E. Goldstein, and R. Horvat. 1998. Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts. Virology 249:140-149.
6. Chang, Y., E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles, and P. S. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1863-1869.
7. Coscoy, L., D. J. Sanchez, and D. Ganem. 2001. A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. J. Cell Biol. 155:1265-1273.
8. Duprez, R., E. Kassa-Kelembho, S. Plancoulaine, J. Briere, M. Fossi, U. Kobangue, P. Minsart, M. Huerre, and A. Gessain. 2005. Human herpesvirus 8 serological markers and viral load in patients with AIDS-associated Kaposi's sarcoma in Central African Republic. J. Clin. Microbiol. 43:4840-4843.
9. Franceschi, S., L. Dal Maso, P. Pezzotti, J. Polesel, C. Braga, P. Piselli, D. Serraino, G. Tagliabue, M. Federico, S. Ferretti, V. De Lisi, F. La Rosa, E. Conti, M. Budroni, G. Vicario, S. Piffer, F. Pamtelli, A. Giacomin, F. Bellu, R. Tumino, M. Fusco, G. Rezza, et al. 2003. Incidence of AIDS-defining cancers after AIDS diagnosis among people with AIDS in Italy. 1986-1998. J. Acquir. Immune Defic. Syndr. 34:84-90.
10. Gaidano, G., A. Gloghini, V. Gattei, M. F. Rossi, A. M. Cilia, C. Godeas, M. Degan, T. Perin, V. Canzonieri, D. Aldinucci, D. Capello, G. Saglio, A. Pinto, and A. Carbone. 1997. KSHV/HHV-8(+) primary effusion lymphoma associates with CD138/syndecan-1 and other plasma cell-specific markers: histogenetic and pathogenetic implications. Blood 90:4894-4900.
11. Gaidano, G., A. Gloghini, V. Gattei, M. F. Rossi, A. M. Cilia, C. Godeas, M. Degan, T. Perin, V. Canzonieri, D. Aldinucci, G. Saglio, A. Carbone, and A. Pinto. 1997. Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen. Blood 90:4894-4900.
12. Gao, S. J., L. Kingsley, D. R. Hoover, T. J. Spira, C. R. Rinaldo, A. Saah, J. Phair, R. Detels, P. Parry, Y. Chang, and P. S. Moore. 1996. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N. Engl. J. Med. 335:233-241.
13. Garber, A. C., M. A. Shu, J. Hu, and R. Renne. 2001. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 75:7882-7892.
14. George, T. C., D. A. Basiji, B. E. Hall, D. H. Lynch, W. E. Ortyn, D. J. Perry, M. J. Seo, C. A. Zimmerman, and P. J. Morrissey. 2004. Distinguishing modes of cell death using the ImageStream ® multispectral imaging flow cytometer. Cytometry Part A 59:237-245.
15. Glannsinger, B., and D. Ganem. 2004. Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis. J. Exp. Med. 200:391-398.
16. Glannsinger, B., and D. Ganem. 2004. Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol. Cell 13:713-723.
17. Hammock, L., A. Reisenauer, W. Wang, C. Cohen, G. Birdsong, and A. L. Folpe. 2005. Latency-associated nuclear antigen expression and human herpesvirus-8 polymerase chain reaction in the evaluation of Kaposi sarcoma and other vascular tumors in HIV-positive patients. Mod. Pathol. 18:463-468.
18. Jenner, R. G., K. Maillard, N. Cattini, R. A. Weiss, C. Boshoff, R. Wooster, and P. Kellam. 2003. Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc. Natl. Acad. Sci. USA 100:10399-10404.
19. Jupp, R., S. Hoffmann, R. M. Stenberg, J. A. Nelson, and P. Ghazal. 1993. Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain. J. Virol. 67:7539-7546.
20. Kedes, D. H., M. Lagunoff, R. Renne, and D. Ganem. 1997. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J. Clin. Investig. 100:2606-2610.
21. Kedes, D. H., E. Operskalski, M. Busch, J. Flood, R. Koha, and D. Ganem. 1996. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Clin. Infect. Dis. 23:249.
22. Kudoh, A., M. Fujita, L. Zhang, N. Shirata, T. Daikoku, Y. Sugaya, H. Isomura, Y. Nishiyama, and T. Tsurumi. 2005. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J. Biol. Chem. 280:8156-8163.
23. Li, M. T., J. MacKey, S. C. Czajak, R. C. Desrosiers, A. A. Lackner, and J. U. Jung. 1999. Identification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoprotein. J. Virol. 73:1341-1349.
24. Liao, W., Y. Tang, S. F. Lin, H. J. Kung, and C. Z. Giam. 2003. K-bZIP of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) binds KSHV/HHV-8 Rta and represses Rta-mediated transactivation. J. Virol. 77:3809-3815.
25. Lukac, D. M., J. R. Kirshner, and D. Ganem. 1999. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 73:9348-9361.
26. Lukac, D. M., R. Renne, J. R. Kirshner, and D. Ganem. 1998. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252:304-312.
27. Luna, R. E., F. C. Zhou, A. Baghiau, V. Chouljenko, B. Forghani, S. J. Gao, and K. G. Kousoulas. 2004. Kaposi's sarcoma-associated herpesvirus glycoprotein K8.1 is dispensable for virus entry. J. Virol. 78:6389-6398.
28. Matsumura, S., V. Fujita, K. Gomez, N. Tanese, and A. C. Wilson. 2005. Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50). J. Virol. 79:8493-8505.
29. Medveczky, M. M., E. Horvath, T. Lund, and P. G. Medveczky. 1997. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS 11:1327-1332.
30. Nakamura, H., M. Lu, V. Gwack, J. Souvlis, S. L. Zeichner, and J. U. Jung. 2003. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J. Virol. 77:4205-4220.
31. Nealon, K., W. W. Newcomb, T. R. Pray, C. S. Craik, J. C. Brown, and D. H. Kedes. 2001. Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus. J. Virol. 75:2866-2878.
32. Pak, F., P. Pyakural, P. Kokhaci, K. Kaaya, A. A. Pourfathollah, G. Selivanova, and P. Biberfeld. 2005. HHV-8/KSHV during the development of Kaposi's sarcoma: evaluation by polymerase chain reaction and immunohistochemistry. J. Cutan. Pathol. 32:21-27.
33. Parravicini, C., B. Chandran, M. Corbellino, K. Berti, M. Paulli, P. S. Moore, and V. Chang. 2000. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am. J. Pathol. 156:743-749.
34. Parsons, C. H., L. A. Adang, J. Overdevest, C. M. O'Connor, J. R. Taylor, D. Camerini, and D. H. Kedes. 2006. KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice. J. Clin. Investig. 116:1963-1973.
35. Preston, C. M., and M. J. Nicholl. 2006. Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. J. Gen. Virol. 87:1113-1121.
36. Raab, M. S., J. C. Albrecht, A. Birkmann, S. Yaguboglu, D. Lang, B. Fleckenstein, and F. Neipel. 1998. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J. Virol. 72:6725-6731.
37. Rabkin, C. S., R. J. Biggar, M. S. Baptiste, T. Abe, B. A. Kohler, and P. C. Nasca. 1993. Cancer incidence trends in women at high risk of human immunodeficiency virus (HIV) infection. Int. J. Cancer 55:208-212.
38. Rainbow, L., G. M. Platt, G. R. Simpson, R. Sarid, S. J. Gao, H. Stoiber, C. S. Herrington, P. S. Moore, and T. F. Schulz. 1997. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J. Virol. 71:5915-5921.
39. Renne, R., W. Zhong, B. Herndier, M. McGrath, N. Abbey, D. Kedes, and D. Ganem. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2:342-346.
40. Sakakibara, S., K. Ueda, K. Nishimura, F. Do, E. Ohsaki, T. Okuno, and K. Yamanishi. 2004. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen. J. Virol. 78:7299-7310.
41. Sanchez, D. J., L. Coscoy, and D. Ganem. 2002. Functional organization of MIR2, a novel viral regulator of selective endocytosis. J. Biol. Chem. 277:6124-6130.
42. Shaw, R. N., J. L. Arbiser, and M. K. Offermann. 2000. Valproic acid induces human herpesvirus 8 lytic gene expression in BCBL-1 cells. AIDS 14:899-902.
43. Si, M. W., J. Jagirdar, Y. J. Zhang, S. J. Gao, and I. T. Yeh. 2005. Detection of KSHV in transbronchial biopsies in patients with Kaposi sarcoma. Appl. Immunohistochem. Mol. Morphol. 13:61-65.
44. Sun, R., S. F. Lin, L. Gradoville, Y. Yuan, F. X. Zhu, and G. Miller. 1998. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 95:10866-10871.
45. Sun, R., S. F. Lin, K. Staskus, L. Gradoville, E. Grogan, A. Haase, and G. Miller. 1999. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J. Virol. 73:2232-2242.
46. Suscovich, T. J., M. Paulose-Murphy, J. D. Harlow, Y. D. Chen, S. Y. Thomas, T. J. Mellott, B. D. Walker, D. T. Scadden, S. Zeichner, and C. Brander. 2004. Defective immune function of primary effusion lymphoma cells is associated with distinct KSHV gene expression profiles. Leuk. Lymphoma 45:1223-1238.
47. Taylor, M. M., B. Chohan, L. Lavreys, W. Hassan, M. L. Huang, L. Corey, R. A. Morrow, B. A. Richardson, K. Mandaliya, J. Ndinya-Achola, J. Bwayo, and J. Kreiss. 2004. Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women. J. Infect. Dis. 190:484-488.
48. Tomesen, C., W. K. Law, and D. H. Kedes. 2003. Surface downregulation of major histocompatibility complex class 1, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus. J. Virol. 77:9669-9684.
49. van Eugeland, M., L. J. Nieland, F. C. Ramaekers, B. Schutte, and C. P. Reutelingsperger. 1998. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31:1-9.
50. Wang, L., N. Wakisaka, C. C. Tomlinson, S. M. DeWire, S. Krall, J. S. Pagano, and B. Damania. 2004. The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res. 64:2774-2781.
51. White, E. A., C. L. Clark, V. Sanchez, and D. H. Spector. 2004. Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression. J. Virol. 78:1817-1830.
52. Xu, Y. Y., D. P. AuCoin, A. R. Huete, S. A. Cei, L. J. Hanson, and G. S. Pari. 2005. A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication. J. Virol. 79:3479-3487.
53. Yada, K., E. Do, S. Sakakibara, E. Ohsaki, E. Ito, S. Watanabe, and K. Ueda. 2006. KSHV RTA induces a transcriptional repressor, HEY1 that represses rta promoter. Biochem. Biophys. Res. Commun. 345:410-418.
54. Ye, F. C., F. C. Zhou, S. M. Yoo, J. P. Xie, P. J. Browning, and S. J. Gao. 2004. Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence. J. Virol. 78:11121-11129.
55. Yu, Y. M., J. B. Black, C. S. Goldsmith, P. J. Browning, K. Bhalla, and M. K. Offermann. 1999. Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells. J. Gen. Virol. 80:83-90.
56. Zhu, L. J., V. Puri, and B. Chandran. 1999. Characterization of human herpesvirus-8 K8.1A/B glycoproteins by monoclonal antibodies. Virology 262:237-249.
57. Ziegler, J. L., A. C. Templeton, and C. L. Vogel. 1984. Kaposis sarcoma-a comparison of classical, endemic, and epidemic forms. Semin. Oncol. 11:47-52.
58. Zoeteweij, J. P., S. T. Eyes, J. M. Orenstein, T. Kawamura, L. J. Wu, B. Chandran, B. Forghani, and A. Blauvelt. 1999. Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: characterization of antiherpesvirus agents. J. Virol. 73:5894-5902.